Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palivizumab for prevention of RSV-associated wheeze in preterm infants
NL-OMON23199Active, not recruiting
- Start
- Oct 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial in respiratory syncytial virus disease (RSV) comparing Palivizumab with Placebo (2 arms). Primary endpoint: Number of wheezing days during the first year of life. Started Oct 2007; status: active, not recruiting.
02
Drugs
palivizumab
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on NL-OMON23199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23199.